Skip to main content

When $7 Trillion Wakes Up: Buy These 3 Dividend Stocks Before Everyone Else Does


Imagine this: over $7 trillion dollars just sitting on the sidelines, waiting for a reason to pounce. That’s the current state of U.S. money market funds. Parked in cash equivalents, these trillions are earning modest yields and biding their time. But nothing sleeps forever—especially not that kind of money. At some point, whether due to lower interest rates, fear of missing out, or a stampede toward yield, that capital is going to move. And when it does, it’s going to chase opportunity.

The smart money knows that before a wave hits, you don’t wait on the beach—you paddle out early and ride it in. So before the herd moves, it might be time to look at a few dividend-paying stocks that are quietly positioned to shine. And by shine, we mean provide stable income, possible price appreciation, and a lot less heartburn than the next meme stock.

Here are three dividend-paying titans worth your attention: Lockheed Martin (LMT), AbbVie (ABBV), and VICI Properties (VICI). These aren't your Reddit darlings. They’re steady, resilient, and boring in all the best ways.


Why $7 Trillion Matters More Than Ever

When interest rates are high, cash earns respect. But if the Fed even hints at cutting rates, the story changes fast. Yield-chasing behavior kicks in. Dividends start to look sexy again. Right now, investors are perfectly content collecting 4-5% in money market accounts, sipping lattes, and watching inflation recede. But the moment those yields get clipped by even a fraction, there will be a rush.

Historically, when money flows out of cash, it doesn't just dribble out. It surges. And dividend stocks—especially high-quality ones—are first in line to benefit. Why? Because they strike a sweet spot between risk and reward. They offer income and some growth, all while being less volatile than growth-only names.

So let’s talk about the three dividend stocks you should get to know before the crowd wakes up and stampedes in your direction.


1. Lockheed Martin (LMT): War Never Sleeps

Current Dividend Yield: ~2.8%
Sector: Aerospace & Defense

Let’s be honest. Defense stocks are the least glamorous tickers in your portfolio. But they’re also some of the most reliable. Lockheed Martin is a prime example. While everyone else panics over the next rate decision, LMT just keeps doing what it does best: building fighter jets, missiles, and national security infrastructure.

More importantly, governments don’t just cut back on defense budgets overnight. In fact, if you check global headlines, most nations are beefing up their military spending. The U.S. alone is spending upwards of $850 billion on defense in 2025. And Lockheed Martin is one of the main recipients of those juicy contracts.

LMT has increased its dividend every year for the past two decades. That’s not just reliable—it’s aristocratic. Even during downturns, the company has demonstrated solid earnings and robust cash flow. It uses this to reward shareholders while also buying back stock.

If you're looking for a dividend that’s as close to bulletproof as it gets, Lockheed Martin should be near the top of your watchlist.


2. AbbVie (ABBV): Big Pharma, Bigger Dividends

Current Dividend Yield: ~3.9%
Sector: Healthcare

AbbVie is the pharmaceutical giant that always seems to get lumped in with the usual suspects, but it's far more interesting than your average pill pusher. A spin-off from Abbott Labs, AbbVie was once known solely for Humira. Since then, it’s expanded into neuroscience, oncology, immunology, and aesthetics (hello, Botox).

Here’s the thing: Humira's patent expired, and the market panicked. But AbbVie had a plan. It pivoted to newer drugs like Skyrizi and Rinvoq—both of which are seeing explosive growth. Add to that the Allergan acquisition, and you've got a diversified earnings engine.

And yet, the stock is still undervalued by most metrics. AbbVie is trading at a forward P/E ratio well below many of its peers, despite outpacing them in both earnings and revenue growth. Plus, they’ve increased their dividend for 51 consecutive years (if you count their Abbott roots).

AbbVie isn’t just a dividend payer; it’s a dividend grower. In the income investing world, that’s a big deal. A fat yield is nice. A fat yield that grows? That’s the holy grail.


3. VICI Properties (VICI): Bet on the House

Current Dividend Yield: ~5.5%
Sector: Real Estate Investment Trust (REIT)

You’ve heard the phrase, “the house always wins.” Well, VICI Properties is the house.

A REIT specializing in entertainment, hospitality, and gaming real estate, VICI owns many of the most iconic properties on the Las Vegas Strip—Caesars Palace, MGM Grand, Venetian, and more. It doesn’t run the casinos; it just collects the rent. And those rent checks are long-term, triple-net leases with inflation escalators. That means tenants pay for taxes, maintenance, and insurance, while VICI rakes in predictable cash flow.

Even better? VICI continues expanding. It recently acquired properties in Canada and formed partnerships in the hospitality sector outside of gaming. Diversification, strong tenants, and solid balance sheets make VICI a REIT investor’s dream.

And did we mention the yield? At over 5%, VICI offers the kind of consistent income that bondholders dream about, without the interest rate sensitivity. Even if rates fluctuate, VICI’s contractual rent increases provide a built-in hedge.


What These Three Have in Common

Besides their dividends, what links LMT, ABBV, and VICI? Resilience. These companies operate in sectors that don’t crumble when the economy sneezes. Defense, healthcare, and real estate tied to human entertainment needs aren’t going out of style.

They also generate significant free cash flow—the lifeblood of sustainable dividends. Companies can fake earnings with accounting tricks, but cash can’t lie. When you see healthy payout ratios and cash flow to cover dividends multiple times over, that’s your signal.

Lastly, all three have room for capital appreciation. These aren’t just yield traps. They have catalysts that could push their stock prices higher, whether it’s new government contracts (LMT), drug approvals (ABBV), or strategic acquisitions (VICI).


Why Buy Now?

Because when $7 trillion wakes up, it doesn’t stretch, yawn, and take a lap. It moves. Fast. Dividend stocks like these could get bid up rapidly as investors start rebalancing from cash to equities.

Think of this as your front-row seat to the money show. Buying before the wave hits means locking in higher yields and enjoying capital gains while everyone else tries to catch up.

Also, consider reinvestment. When you buy high-quality dividend stocks early, you benefit from compounding. Dividends can be reinvested at lower prices today to accumulate more shares, which then produce more income. Over time, this creates an accelerating income snowball.


Final Thoughts: Don’t Hit Snooze

Cash may feel safe, but it’s sleeping. And sleep, in the investing world, is costly. The opportunity cost of waiting for the “perfect” entry point can often outweigh the risks of moving early into quality assets.

Lockheed Martin, AbbVie, and VICI Properties aren’t speculative plays. They’re not going to make you rich overnight. But they are the types of dividend stocks that offer peace of mind, income, and the potential for price appreciation—the three-headed dragon of smart investing.

So when that $7 trillion wakes up, make sure you’re already in position. The stampede will come. The question is whether you’ll be watching it from behind or leading the charge.

Don’t wait. Be early. Be smart. Be invested.

Comments

Popular posts from this blog

Nebius: A 10x AI Growth Story Still Flying Under Wall Street’s Radar

In the world of explosive AI growth stories, few companies combine the stealth, ambition, and scale of Nebius Group N.V. (NASDAQ: NBIS). While Wall Street fawns over the Magnificent Seven and scrambles to understand how OpenAI, Anthropic, and others fit into the commercial AI puzzle, Nebius is quietly building a European AI infrastructure empire—and it’s about to cross the Atlantic. Despite a 20% decline in the stock since February 2025, the company is arguably one of the most compelling under-the-radar growth stories in AI today. If you're a long-term investor searching for the next 10-bagger hiding in plain sight, this one deserves your attention. The Dip Isn't the Story—The Growth Is Let’s begin with the obvious: Nebius stock is down 20% from its recent high. For most momentum chasers, that's a red flag. But the market correction has been broad-based, with the S&P 500 itself in the throes of a selloff sparked by political uncertainty and concerns over rates. Th...

Supercharge Your Retirement With Income Machines Paying Fat Dividends

Retirement planning can be a daunting task, but building a portfolio filled with reliable, high-yielding dividend stocks and funds can make it significantly easier. Instead of relying on the traditional 4% rule, where you gradually sell assets to fund your retirement, you can live off dividends indefinitely, preserving your principal while enjoying a steady income stream. By focusing on investments with strong, durable business models, robust balance sheets, and dividend growth that outpaces inflation, retirees can achieve financial security and even benefit from market downturns by reinvesting excess cash flow. In this article, we’ll explore six income-generating investments—three funds and three individual stocks—that can help supercharge your retirement. Fund #1: Schwab U.S. Dividend Equity ETF (SCHD) SCHD is a go-to dividend growth ETF with a well-balanced portfolio of 101 high-quality companies. While its 3.6% dividend yield may be on the lower end for some retirees, its consisten...

Higher High, Lower High; AMD Is A Buy

In the ever-volatile world of semiconductors, Advanced Micro Devices (NASDAQ: AMD) (TSX: AMD:CA) is showing all the hallmarks of a classic breakout opportunity—one that savvy investors would be wise not to overlook. Despite a near 50% pullback from its peak, AMD's fundamentals have never looked stronger. And while investor sentiment has temporarily soured, the underlying growth momentum tells a completely different story. We’re witnessing the convergence of a rare market anomaly: robust fundamentals + depressed valuation = opportunity. This is a textbook “higher high, lower high” setup in technical and sentiment terms—when a strong company’s fundamentals climb higher even as its stock price dips lower. Eventually, these two trends reconcile, and when they do, patient investors often see outsized gains. Table of Contents AMD: From Hero to Underdog—Again Unpacking AMD’s Growth Narrative Why the Momentum Is Not Just Sustainable—But Accelerating The Market Is Pricing AMD ...